IntelliGenes, a new software at Rutgers Health, uses artificial intelligence and machine learning to measure the significance of genomic biomarkers, potentially predicting diseases. The software, which merges traditional statistical methods with state-of-the-art algorithms, is intuitive enough for non-experts to use. In a study, IntelliGenes was used to discover novel biomarkers and accurately predict cardiovascular disease.
Dispersed responsibility, lack of asset inventory is causing gaps in medical device cybersecurity
Witnesses at a House hearing on medical device cybersecurity highlighted the need for better tracking of devices and their vulnerability to cyber threats. They noted
